Development and Validation of Predictive Models for Differentiating Resectable Stage III Peripheral SCLC from NSCLC Using Radiomic Features and Clinical Parameters
Objective Lung cancer is primarily categorized into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), each characterized by distinct therapeutic approaches and prognostic outcomes, particularly in stage III peripheral cases. This study aimed to develop predictive models utilizing...
Saved in:
| Main Authors: | Junjie Zhang MD, Ligang Hao MD, Qiuxu Zhang MD, Lina Zheng MD, Qian Xu PhD, Fengxiao Gao MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251368956 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Inoperable Stage III NSCLC Treated with Concurrent Radiochemotherapy Plus PD-1 Inhibitors
by: Ya Li Bachelor, et al.
Published: (2025-06-01) -
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature
by: Marianna Peroni, MD, et al.
Published: (2025-08-01) -
Validation and Repeatability of Differential Light Sensitivity Measurements with the Novel MAIA Microperimetry Device
by: Georg Ansari, MD, et al.
Published: (2025-11-01) -
A 3-dimensional model for bronchial and arterial sleeve resectionCentral Message
by: Yoshifumi Hirata, MD, et al.
Published: (2025-02-01)